Catalyst Wire Dossier Catalyst Wire Dossier

21-valent pneumococcal conjugate vaccine

Pneumococcal conjugate vaccine, 21-valent · Sanofi
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for 21-valent pneumococcal conjugate vaccine, covering 2026-02-13 to 2026-04-27. Get the full timeline:

Most recent: Clinical Trial Update: Lot-to-lot Consistency Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From 2 Months of Age [Phase 3]

See pricing